GLP-1 receptor agonists may improve outcomes in idiopathic intracranial hypertension
by Elana Gotkine edited by Andrew Zinin For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved clinical outcomes compared with conventional therapies, according to a study published online July 14 in JAMA Neurology. Georgios S. Sioutas, M.D., from the Virginia Commonwealth University Health System in Richmond, and […]
GLP-1 receptor agonists may improve outcomes in idiopathic intracranial hypertension Read More »
